Cen Biotech Stock Price Patterns
| CENBF Stock | USD 0.0001 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using CEN Biotech hype-based prediction, you can estimate the value of CEN Biotech from the perspective of CEN Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CEN Biotech to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying CEN because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CEN Biotech after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CEN |
CEN Biotech After-Hype Price Density Analysis
As far as predicting the price of CEN Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CEN Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of CEN Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CEN Biotech Estimiated After-Hype Price Volatility
In the context of predicting CEN Biotech's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CEN Biotech's historical news coverage. CEN Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered CEN Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CEN Biotech is very steady at this time. Analysis and calculation of next after-hype price of CEN Biotech is based on 3 months time horizon.
CEN Biotech Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as CEN Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CEN Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CEN Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.0001 | 0.00 |
|
CEN Biotech Hype Timeline
CEN Biotech is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. CEN is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on CEN Biotech is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 54.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.41. CEN Biotech had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out CEN Biotech Basic Forecasting Models to cross-verify your projections.CEN Biotech Related Hype Analysis
Having access to credible news sources related to CEN Biotech's direct competition is more important than ever and may enhance your ability to predict CEN Biotech's future price movements. Getting to know how CEN Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CEN Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BLMS | Bloomios | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WOWU | WOWI Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MJNE | MJ Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SESI | SES Solar | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| UPPR | Upper Street Marketing | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VIVXF | Avivagen | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SAGD | South American Gold | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WUHN | Wuhan General Gr | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 300.00 | |
| DNAG | DNAPrint Genomics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SPLM | Sentry Petroleum | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CEN Biotech Additional Predictive Modules
Most predictive techniques to examine CEN price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CEN using various technical indicators. When you analyze CEN charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CEN Biotech Predictive Indicators
The successful prediction of CEN Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CEN Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CEN Biotech based on analysis of CEN Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CEN Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CEN Biotech's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for CEN Pink Sheet analysis
When running CEN Biotech's price analysis, check to measure CEN Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CEN Biotech is operating at the current time. Most of CEN Biotech's value examination focuses on studying past and present price action to predict the probability of CEN Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CEN Biotech's price. Additionally, you may evaluate how the addition of CEN Biotech to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |